These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1312221)

  • 21. Herpes simplex virus infection in populations of mouse dorsal root ganglion neurons: effects of inoculation route and virus strain.
    Henken DB; Martin JR
    J Neurol Sci; 1991 Sep; 105(1):29-36. PubMed ID: 1665505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J; Szczesiul MS; Marlin SD; Levine M
    Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of purified glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Nishiyama K; Ohtomo N; Mori R
    Arch Virol; 1986; 89(1-4):69-80. PubMed ID: 3013134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide sequences responsible for the inability of a herpes simplex virus type 2 strain to grow in human lymphocytes are identical to those responsible for its inability to grow in mouse tissues following ocular infection.
    Lausch RN; Yeung KC; Miller JZ; Oakes JE
    Virology; 1990 Jun; 176(2):319-28. PubMed ID: 2161143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.
    Atanasiu D; Saw WT; Lazear E; Whitbeck JC; Cairns TM; Lou H; Eisenberg RJ; Cohen GH
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2.
    Bystrická M; Vancíková M; Kasalová M; Rajcáni J; Kostál M; Murányiová M; Poláková K; Russ G
    Acta Virol; 1991 Apr; 35(2):152-64. PubMed ID: 1681713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system.
    Sunstrum JC; Chrisp CE; Levine M; Glorioso JC
    Virus Res; 1988 Aug; 11(1):17-32. PubMed ID: 2845681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness.
    Yuhasz SA; Stevens JG
    J Virol; 1993 Oct; 67(10):5948-54. PubMed ID: 8396662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection.
    Eis-Hübinger AM; Mohr K; Schneweis KE
    Intervirology; 1991; 32(6):351-60. PubMed ID: 1657825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane.
    Fontana J; Atanasiu D; Saw WT; Gallagher JR; Cox RG; Whitbeck JC; Brown LM; Eisenberg RJ; Cohen GH
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.
    Oakes JE; Lausch RN
    J Virol; 1984 Sep; 51(3):656-61. PubMed ID: 6088790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein variability in herpes simplex virus type 1 strains by radioimmunoprecipitation with monoclonal antibodies.
    al-Ahdal MN
    Microbios; 1993; 74(299):95-102. PubMed ID: 8395644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
    Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
    J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.
    Showalter SD; Zweig M; Hampar B
    Infect Immun; 1981 Dec; 34(3):684-92. PubMed ID: 6277788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants.
    Cecilia D; Gould EA
    Virology; 1991 Mar; 181(1):70-7. PubMed ID: 1704661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.
    Dix RD; Mills J
    J Med Virol; 1985 Sep; 17(1):9-18. PubMed ID: 2995573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia.
    Subak-Sharpe JH; Al-Saadi SA; Clements GB
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):67s-71s. PubMed ID: 6330225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific deposition of passively transferred monoclonal antibodies against herpes simplex virus type 1 in rat brain infected with the virus.
    Tamada K; Fujinaga S; Watanabe R; Yamashita R; Takeuchi Y; Osano M
    Microbiol Immunol; 1995; 39(11):861-71. PubMed ID: 8657013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.